SYMPOSIUM

2026

  • eadv.org
EADV Logo

EADV Symposium scientific programme

Every year, the EADV Scientific Programming Committee develops a dynamic 3-day agenda tailored to the needs of both emerging dermatologists-venereologists and experienced specialists.

The programme brings together leading experts and offers participants the opportunity to engage with a broad spectrum of topics through a carefully selected range of sessions.

Programme booklet
FULL PROGRAMME
Abstracts
Credits & Certificates

Welcome letter from the SPC Chair

Dear Collegues and Friends,

On behalf of the Scientific Programming Committee, I am delighted to welcome you to the 2025 EADV Spring Symposium in Prague.

We have crafted an exciting program that covers a vast array of clinical topics. With over 25 educational sessions and more than 100 thought-provoking talks spread across three specialized tracks, there is something for everyone!

One of the highlights of the symposium is the Plenary Lecture by Professor Bohdan Pomahac from Yale University. Professor Pomahac is renowned for performing the first full-face transplants. His talk, “The Many Faces of Full-Face Transplantation,” promises to be a fascinating and unmissable lecture that will set the stage for an incredible event.

Here is what you can look forward to:

Track one will feature “Focus on” sessions providing a one-day deep-dive into two timely topics of great interest: “New targeted treatments” and “Viral infections”.

Track two will feature “what’s new” sessions, which will allow you to stay ahead of the curve with the latest updates on melanoma, hidradenitis suppurativa, psoriasis and lupus erythematosus and more! Plus, do not miss the joint session with IUSTI for a comprehensive update on STIs.

Track three will be dedicated to interactive sessions, a crowds-favorite of our Spring Symposia! Test your diagnostic and management skills with case-based quizzes in dermoscopy, hair, nail, aesthetics and pediatrics. Back by popular demand, we will also feature challenging case presentations from residents to faculty, offering an unparallelled opportunity to refine your clinical reasoning and problem-solving skills.

And that is not all! The best-rated abstracts will take centre-stage during the Free Communications session, where presenters will showcase their latest findings and breakthroughs.

I hope to see you all in Prague for this unforgettable Symposium!

 

Prof. Michel Gilliet – Chair of the SPC

Scientific Programming Committee: Michel Gilliet (Chair of the SPC),  Jo Lambert, Paola Pasquali, Lidia Rudnicka, Eli Sprecher, Thrasyvoulos Tzellos

Session types

Sessions of different formats will cover the most important topics in dermatology and venereology. Subjects will be treated with different approaches and from different perspectives depending on the type and structure of the session.

The Plenary lectures are EADV show-case sessions and include key-note lectures delivered by eminent scientists and doctors.

These sessions will enable participants to update their knowledge on a specific topic and hear about the most relevant and recent developments, guidelines and practical knowledge from the past year. The talks will summarize the current understanding of the subject, followed by an update on the most recent novelties with their impact on clinical practice.

These sessions aim at providing comprehensive in-depth coverage of a certain topic in dermatology. The talks will be included in sessions on pathophysiology / epidemiology, clinical challenges, or practical aspects of disease management and will provide the latest cutting-edge information.

These lectures focus on a specific disease and include basic information about epidemiology, pathophysiology, diagnosis, management and prognosis. 

The target audience of these sessions is young dermatology trainees and residents, as well as dermatologists that want to refresh their basic knowledge on specific topics. 

The topic of each presentation should be developed from clinical cases and include clinical photographs. The main objective is to provide the audience clues for differential diagnosis and disease management in their daily practice. 

Each presentation is supposed to be interactive, with multiple-choice question made to the audience in accordance with the subjects treated in the talks. Each speaker will be asked to include 2-3 questions by “data” along with the different answers’ options.

Authors of the most highly-ranked abstracts assessed by a selected panel of abstract reviewers are invited to a provide a 10-minute oral presentation.

Programme at a glance

Thursday, 7 May 2026

Swipe to scroll horizontally

  14:00 – 15:3015:45 – 17:1517:30 – 18:30
TRIANTI HALL Technical innovationsBullous diseasesPlenary session
BANQUETING HALL Focus on hair disorders: Non-cicatricial alopeciaFocus on hair disorders: Cicatricial alopecia 
SKALKOTAS HALL Free CommunicationsFree Communications 

Friday, 8 May 2026

Swipe to scroll horizontally

 09:00 – 10:3010:45 – 12:1514:00 – 15:3015:45 – 17:15
TRIANTI HALLAtopic dermatitisOverlapping dermatological diseasesAcneKeratinocytic skin cancer
BANQUETING HALLDermoscopyAesthetic dermatologyClincal pathological correlationThe hot seat: Local residents quiz the international faculty
SKALKOTAS HALLFocus on folliculitisFocus on nail disordersFocus on paediatric dermatology: NeonatalFocus on paediatric dermatology: Emergencies

Saturday, 9 May 2026

Swipe to scroll horizontally

 09:00 – 10:3010:45 – 12:1512:30 – 14:00 
TRIANTI HALLTrichoscopyTumoursInflammatory diseases 
BANQUETING HALLFocus on paediatric dermatology: Through the agesFocus on paediatric dermatology: TherapeuticsPaediatric dermatology: test yourself 
SKALKOTAS HALLNaevi and melanomaPrevention of STIJoint EADV-IUSTI-EU session on venereology 

Scientific session spotlights

Atopic dermatitis

What's new

  • Friday, 8 May
  • 9:00 - 10:30 EEST
  • Trianti Hall
READ MORE

Pathogenesis and endotypes

Maciej Pastuszczak, Poland

Lifestyle, prevention and disease modification

Mette Sondergaard Deleuran, Denmark

Comorbidities: Management and workup

Stamatis Gregoriou, Greece

Treatment

Marie-Aleth Richard, France (Chair)

Stay informed with the latest advancements and expert insights from EADV

SCIENTIFIC SPOTLIGHTS

If you have any questions about the Scientific Programme, Abstracts, CME Accreditation, or Certificates, please contact our Scientific Team

Healthcare Professional definition

  1. Important note to Healthcare and Non-Healthcare Professionals

    Access to the different areas and sessions of the Symposium is determined by the attendee’s Healthcare Professional status.

    As a multidisciplinary audience will attend the EADV Congress, the EADV will assign different classes to Healthcare Professionals (HCPs) and Non-Healthcare Professionals (non-HCPs) to ensure compliance with the Hellenic Association of Pharmaceutical Companies (SFEE’s Promotion Code) (CODE OF ETHICS & PARTNERSHIPS | SFEE).
    Please read the description below to ensure that you (or your delegates) comply with the regulations in place.

EADV members are not automatically considered Healthcare Professionals

Please select the correct status (HCP or non-HCP) during registration.

  1. Definition The SFEE code defines Healthcare Professionals as follows (Definitions, page 6):“any natural person who is identified as a healthcare professional in the applicable legislation1 and whose primary practice or principal professional address is in Greece and who, in the course of his/her professional activities, may prescribe, purchase, supply, recommend or administer medicinal products.

    It is explicitly clarified that the very broad subset of Healthcare Professionals who are not legally entitled to prescribe, supply or administer medicinal products, but nevertheless belong to the category of Healthcare Professionals, are not considered as general public. In this sense, product promotions at scientific event venues where such persons may be present are no prohibited.

    In the context of the national cancer policy, the specialty of pathologists is also explicitly included in this definition.

    To avoid any doubt, the term“Healthcare Professional”, with the exception of Chapter 1

    hereof, also includes:

    1. any official or employee of a government agency or other organisation (whether in the public or private sector) who may prescribe, purchase, supply, recommend or administer Medicinal Products; and
    2. any employee of a Pharmaceutical Company whose primary occupation is that of a practising HCP (e.g. medical doctor, nurse, dentist, etc.).
    However, the definition excludes:
    • all other full-term personnel (whether HCPs or not) of a PC under an employment contract, professional service contract or independent work contract; and
    • wholesalers or distributors of Medicinal Products.”

    Article 4 of Law 4238/GG A, 38/17.02.2014, characterises the following persons as Healthcare Professionals (HCPs): family physicians and physicians of other specialties, dentists and other healthcare professionals such as midwives, health visitors, nurses, social workers, physiotherapists, dieticians/nutritionists, psychologists, occupational therapists, medical laboratory technologists, medical and biological laboratory assistants, medical equipment operators.

    Medical students are not considered Healthcare Professionals under the current guidelines and will be automatically classified as Non-Healthcare Professionals.

  1. Industry sessions

    Satellite Symposia presenting data on the development, research, or other issues related to prescription medicine is restricted to Healthcare Professionals and Non Member (INDUSTRY) as indicated by the Industry Session Organizer.
    All promotional materials and marketing aids related to these industry sessions should be strictly limited to HCPs.

    Industry Session organisers can limit participation to certain representative groups independently from the EADV recommendations if deemed imperative to achieving the session’s intended purpose. The organising company reserves the right to refuse single categories, particularly if they are not adequately related to the session’s objective and purpose.

    The industry session organiser is responsible for compliance with the session